Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
1(33.3%)
N/A
1(33.3%)
Phase 2
1(33.3%)
3Total
Phase 1(1)
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06612710Phase 1Recruiting

The Safety and Efficacy of NouvSoma001 in Ischemic Stroke

Role: lead

NCT02765581Not ApplicableCompleted

Efficacy Study of Acupuncture in the Prevention of Migraine Without Aura

Role: lead

NCT02782897Phase 2Unknown

Intravenous Immunoglobulin for Acute Intracranial Hemorrhage

Role: lead

NCT02276976Unknown

MRI,Gene And Cognitive Performance Study of Patients With Cerebral White Matter Lesions(WMLs)

Role: lead

All 4 trials loaded